During the past decade, Hospital y Clínica OCA S.A de C.V conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital y Clínica OCA S.A de C.V" #1 sponsor was "Pfizer" with 4 trials, followed by "GlaxoSmithKline" with 2 trials sponsored, "Baxalta now part of Shire" with 1 trials sponsored, "Hospital y Clinica OCA, S.A. de C.V." with 1 trials sponsored and "Mallinckrodt ARD LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital y Clínica OCA S.A de C.V" #1 collaborator was "Bausch Health Americas, Inc." with 1 trials as a collaborator, "Mene Research" with 1 trials as a collaborator, "OCT Clinical Trials" with 1 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital y Clínica OCA S.A de C.V" are "Alzheimer Disease" (2 trials), "Coronary Artery Disease" (1 trials), "Distal, Subungual Onychomycosis" (1 trials), "Epilepsy" (1 trials) and "Idiopathic Focal Segmental Glomerulosclerosis" (1 trials). Many other conditions were trialed in "Hospital y Clínica OCA S.A de C.V" in a lesser frequency.

Most popular intervention types in "Hospital y Clínica OCA S.A de C.V" are "Drug" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "bapineuzumab" (2 trials), "placebo" (2 trials), "AN2690 Solution Vehicle" (1 trials) and "AN2690 Solution, 5.0%" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital y Clínica OCA S.A de C.V" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Hospital y Clínica OCA S.A de C.V". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital y Clínica OCA S.A de C.V, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital y Clínica OCA S.A de C.V, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".